Armata Pharmaceuticals ARMP
NYSE ARMP
$3.70 +0.11 (+3.06%)
As of: Sep 30, 2026 · 3:28 PM EDT

Armata Pharmaceuticals (ARMP) Research & Development (2013 - 2026)

Updated

Armata Pharmaceuticals (ARMP) posted Research & Development of $7.59 million for Q2 2026, up 18.6% from $6.39 million a year earlier and up 24.1% from the prior quarter.

Analysis

Armata Pharmaceuticals (ARMP) Research & Development (2013 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Research & Development at Armata Pharmaceuticals was $25.59 million, down 14.0% year-over-year; for FY2025, it came in at $23.72 million, down 31.1% from FY2024.

  • Annual Research & Development shows a five-year compound annual growth rate of 10.4% (FY2020 to FY2025).
  • In prior years, Armata Pharmaceuticals' Research & Development was $34.43 million in FY2024 (+1.9%), $33.77 million in FY2023 (-3.6%), $35.02 million in FY2022 (+75.0%) and $20.02 million in FY2021 (+38.6%).
  • The Q2 2026 figure stands as the highest quarterly Research & Development since Q4 2024.
  • On a year-over-year basis, Research & Development increased in four of the last eight quarters, with an average decline of 8.4%.
  • The strongest year-over-year quarter for Research & Development in the past five years was Q4 2022, with growth of 98.8%; the weakest was Q3 2025, with a decline of 38.6%.
  • According to Business Quant data, Research & Development for the three prior quarters was $6.11 million (Q1 2026), $6.07 million (Q4 2025) and $5.82 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 3.65 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 2.34 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -4.05 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 993.80 Mn
10 Armata Pharmaceuticals 133.35 Mn 81.07 Mn - 7.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.59 Mn
Mar 31, 2026 6.11 Mn
Dec 31, 2025 6.07 Mn
Sep 30, 2025 5.82 Mn
Jun 30, 2025 6.39 Mn
Mar 31, 2025 5.43 Mn
Dec 31, 2024 8.45 Mn
Sep 30, 2024 9.49 Mn
Jun 30, 2024 8.48 Mn
Mar 31, 2024 8.02 Mn
Dec 31, 2023 7.93 Mn
Sep 30, 2023 7.98 Mn
Jun 30, 2023 8.26 Mn
Mar 31, 2023 9.60 Mn
Dec 31, 2022 9.57 Mn
Sep 30, 2022 8.40 Mn
Jun 30, 2022 9.02 Mn
Mar 31, 2022 8.03 Mn
Dec 31, 2021 4.81 Mn
Sep 30, 2021 5.63 Mn
API Access

Armata Pharmaceuticals Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=ARMP&period=max&api_key=YOUR_API_KEY